For quantification of PGE2 in plasma, urine, and culture media samples
Features
  • Measure PGE2 in multiple sample types
  • Assay 24 samples in triplicate or 36 samples in duplicate
  • Measure PGE2 levels down to 13 pg/ml
  • Incubation: 18 hours | Development: 60-90 minutes | Read: Colorimetric at 405-420 nm
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Prostaglandin E2 ELISA Kit - Monoclonal

Item No. 514010

Kit Booklet (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Synonyms
  • Dinoprostone
  • PGE2
  • PGE2 EIA
Assay Range
7.8-1,000 pg/ml
Sensitivity
80% B/B0: 13 pg/ml
Cross Reactivity
(Prostaglandin E2) 100%(Prostaglandin E2 Ethanolamide) 100%(Prostaglandin E2-1-glyceryl ester) 100%(Prostaglandin E3) 43.0%(Prostaglandin E1) 18.7%(8-iso Prostaglandin E2) 2.5%(Sulprostone) 1.25%(6-keto Prostaglandin F1α) 1.0%(8-iso Prostaglandin F2α) 0.25%(Prostaglandin A2) 0.04%(13,14-dihydro-15-keto Prostaglandin E2) 0.02%(Arachidonic Acid) <0.01%(Arachidonoyl Ethanolamide) <0.01%(O-Arachidonoyl Ethanolamide) <0.01%(Butaprost) <0.01%(Conjugated Linoleic Acid (10E,12Z)) <0.01%(8(S),15(S)-DiHETE) <0.01%(Leukotriene B4) <0.01%(Misoprostol) <0.01%(Misoprostol (free acid)) <0.01%(tetranor-PGEM) <0.01%(tetranor-PGFM) <0.01%(Prostaglandin A1) <0.01%(8-iso Prostaglandin A2) <0.01%(Prostaglandin A3) <0.01%(Prostaglandin B1) <0.01%(Prostaglandin B2) <0.01%(Prostaglandin D2) <0.01%(11-deoxy Prostaglandin E2) <0.01%(16,16-dimethyl Prostaglandin E2) <0.01%(19(R)-hydroxy Prostaglandin E2) <0.01%(20-hydroxy Prostaglandin E2) <0.01%(15-keto Prostaglandin E2) <0.01%(Prostaglandin F1α) <0.01%(Prostaglandin F2α) <0.01%(13,14-dihydro-15-keto Prostaglandin F2α) <0.01%(Prostaglandin F3α) <0.01%(Prostaglandin J2) <0.01%(15-deoxy-Δ12,14-Prostaglandin J2) <0.01%(Thromboxane B2) <0.01%
Origin
Animal/Bovine, Animal/Eel, Animal/Goat, Animal/Mouse
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    96 solid wells

    $438

    Add

    96 strip wells

    $438

    Add

    480 solid wells

    $1,643

    Add

    480 strip wells

    $1,643

    Add
    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    Cayman’s Prostaglandin E2 (PGE2) ELISA Kit - Monoclonal is a competitive assay that can be used for quantification of PGE2 in urine, plasma, tissue culture supernatants, and other sample matrices. The assay has a range from 7.8-1,000 pg/ml, a sensitivity (80% B/B0) of approximately 13 pg/ml, and a lower limit of detection (LLOD) of 11 pg/ml.

    Needed but not supplied: Please download the kit booklet to verify if UltraPure Water (Milli-Q or equivalent) or any other components are needed for this assay.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Citations

    Singla, M., Wang, Y.X., Monti, E., et al. Inhibition of 15-hydroxy prostaglandin dehydrogenase promotes cartilage regeneration. Science eadx6649 (2025).

    Kim, R., Hashimoto, A., Markosyan, N., et al. Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature 612(7939), 338-346 (2022).

    Inazumi, T., Yamada, K., Shirata, N., et al. Prostaglandin E2-EP4 axis promotes lipolysis and fibrosis in adipose tissue leading to ectopic fat deposition and insulin resistance. Cell Rep. 33(2), 108265 (2020).

    Storniolo, C.E., Sacanella, I., Mitjavila, M.T., et al. Bioactive compounds of cooked tomato sauce modulate oxidative stress and arachidonic acid cascade induced by oxidized LDL in macrophage cultures. Nutrients 11(8), E1880 (2019).

    Bielemann, A.M., Marcello-Machado, R.M., Del Bar Cury, A.A., et al. Systematic review of wound healing biomarkers in peri-implant crevicular fluid during osseointegration. Arch. Oral Biol. 89, 107-128 (2018).

    Zhuang, Y., Wang, C., Wu, C., et al. Mitochondrial oxidative stress activates COX-2/mPGES-1/PGE2 cascade induced by albumin in renal proximal tubular cells. Oncotarget 9(10), 9235-9245 (2018).

    Xiao, X., Nakatsu, G., Jin, Y., et al. Gut microbiota mediates protection against enteropathy induced by indomethacin. Sci. Rep. 7, 40317 (2017).

    Yilmaz Doğru, H., Benli, I., and Doğru, S. The oxidative/anti-oxidative effects of sevoflurane on reproductive system of females: An experimental study. Turk. J. Obstet. Gynecol. 14(4), 228-232 (2017).

    Arcanjo, A.F., Nunes, M.P., Silva-Junior, E.B., et al. B-1 cells modulate the murine macrophage response to Leishmania major infection. World J. Biol. Chem. 8(2), 151-162 (2017).

    Sato, K., Mihara, Y., Kanai, K., et al. Tyrosol ameliorates lipopolysaccharide-induced ocular inflammation in rats via inhibition of nuclear factor (NF)-κB activation. J. Vet. Med. Sci. 78(9), 1429-1438 (2016).

    Yoo, J.-M., Yang, J.-H., Kim, Y.S., et al. Inhibitory effect of Loranthus parasiticus on IgE-mediated allergic responses in RBL-2H3 cells. Mediators Inflamm. 2016, 8742562 (2016).

    Toledo, D.A., Roque, N.R., Teixeira, L., et al. Lipid body organelles within the parasite Trypanosoma cruzi: A Role for Intracellular Arachidonic Acid Metabolism. PLoS One 11(8), e0160433 (2016).

    Lupicka, M., Socha, B., Szczepánska, A., et al. Expression of pluripotency markers in the bovine uterus with adenomyosis. Reprod. Biol. Endocrinol. 13, 110 (2015).

    Ercan, S., Kencebay, C., Basaranlar, G., et al. Induction of omega 6 inflammatory pathway by sodium metabisulfite in rat liver and its attenuation by ghrelin. Lipids Health Dis. 14:7, (2015).

    Xiao, W., Yu, A., Liu, D., et al. Ligustilide treatment promotes functional recovery in a rat model of spinal cord injury via preventing ROS production. Int. J. Clin. Exp. Pathol. 8(10), 12005-12013 (2015).

    Liu, Y.-W., Mei, H.-C., Su, Y.-W., et al. Inhibitory effects of Pleurotus tuber-regium mycelia and bioactive constituents on LPS-treated RAW 264.7 cells. J. Funct. Foods 7, 662-670 (2014).

    Zaiss, A.K., Zuber, J., Chu, C., et al. Reversible suppression of cyclooxygenase 2 (COX-2) expression in vivo by inducible RNA interference. PLoS One 9(7), e101263 (2014).

    Lyons, T.R., Borges, V.F., Betts, C.B., et al. Cyclooxygenase-2-dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer. J. Clin. Invest. 124(9), 3901-3912 (2014).

    Nirmal, J., Tyagi, P., Chuang, Y.-C., et al. Functional and molecular characterization of hyposensitive underactive bladder tissue and urine in streptozotocin-induced diabetic rat. PloS One 9(7), e102644 (2014).

    Sanchez, A., Tripathy, D., Yin, X., et al. Sunitinib enhances neuronal survival in vitro via NF-κB-mediated signaling and expression of cyclooxygenase-2 and inducible nitric oxide synthase. J. Neuroinflammation 10, 93 (2013).

    Sun, Y., Jia, Z., Liu, G., et al. PPARγ agonist rosiglitazone suppresses renal mPGES-1/PGE2 pathway in db/db mice. PPAR Res. 2013:e612971, (2013).

    Laavola, M., Nieminen, R., Yam, M.F., et al. Flavonoids eupatorin and sinensetin present in Orthosiphon stamineus leaves inhibit inflammatory gene expression and STAT1 activation. Planta Med. 78(8), 779-786 (2012).

    Zhou, J., Joplin, D.G., Cross, J.V., et al. Sulforaphane inhibits prostaglandin E2 synthesis by suppressing microsomal prostaglandin E synthase 1. PLoS One 11, e49744 (2012).

    Ling, H., Jia, X., Zhang, Y., et al. Pachymic acid inhibits cell growth and modulates arachidonic acid metabolism in nonsmall cell lung cancer A549 cells. Mol. Carcinog. 49(3), 271-282 (2010).

    Stanikunaite, R., Khan, S.I., Trappe, J.-M., et al. Cyclooxygenase-2 inhibitory and antioxidant compounds from the truffle Elaphomyces granulatus. Phytother. Res. 23(4), 575-578 (2009).

    Herrerias, A., Torres, R., Serra, M., et al. Activity of the cyclooxygenase 2-prostaglandin-E prostanoid receptor pathway in mice exposed to house dust mite aeroallergens, and impact of exogenous prostaglandin E2. J. Inflamm. (Lond) 6, 30 (2009).

    Singh, B., Berry, J.A., Shoher, A., et al. COX-2 involvement in breast cancer metastasis to bone. Oncogene 26(26), 3789-3796 (2007).

    Ohtsuki, M., Taketomi, Y., Arata, S., et al. Transgenic expression of group V, but not group X, secreted phospholipase A2 in mice leads to neonatal lethality because of lung dysfunction. The Journal of Biological Chemisty 281(47), 36420-36433 (2006).

    Ochiai, Y., Kaburagi, S., Obayashi, K., et al. A new lipophilic pro-vitamin C, tetra-isopalmitoyl ascorbic acid (VC-IP), prevents UV-induced skin pigmentation through its anti-oxidative properties. J. Dermatol. Sci. 44(1), 37-44 (2006).

    Mayo, J.C., Sainz, R.M., Tan, D.-X., et al. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J. Neuroimmunol. 165(1-2), 139-149 (2005).

    Park, E.K., Choo, M.K., Han, M.J., et al. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int. Arch. Allergy. Immunol. 133(2), 113-120 (2004).

    Jung, M.J., Chung, H.Y., Kang, S.S., et al. Antioxidant activity from the stem bark of Albizzia julibrissin. Arch. Pharm. Res. 26(6), 458-462 (2003).

    Colarow, L., turini, M.E., Teneberg, S., et al. Characterization and biological activity of gangliosides in buffalo milk. Biochim. Biophys. Acta 1631, 94-106 (2003).

    Maihofner, C., Schlotzer-Schrehardt, U., Guhring, H., et al. Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes. Invest. Ophthalmol. Vis. Sci. 42(11), 2616-2624 (2001).

    Yrjänheikki, J., Tikka, T., Keinänen, R., et al. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. PNAS 96(23), 13496-13500 (1999).

    Zhang, Y., Shaffer, A., Portanova, J., et al. Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production. J. Pharmacol. Exp. Ther. 283(3), 1069-1075 (1997).

    Mnich, S.J., Veenhuizen, A.W., Monahan, J.B., et al. Characterization of a monoclonal antibody that neutralizes the activity of prostaglandin E2. J. Immunol. 155, 4437-4444 (1995).